USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 27.18 USD 0.3% Market Closed
Market Cap: 512.6m USD

USANA Health Sciences Inc
Investor Relations

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,978 full-time employees. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Show more
Loading

Earnings Calls

2023 Q3
Nov 9, 2023
Show Transcript
Previous
Next
CANCOM: Profitable Growth Amid Challenges
2023 Q3
Nov 9, 2023

In the third quarter of 2023, CANCOM saw growth in a challenging economic landscape, driven by the acquisition of KBC Group and a focus on service businesses. The group's overall revenue increased, but the demand for e-commerce and workplace infrastructure remained soft, resulting in a decline in EBITDA by 4.3% and the EBITDA margin sliding from 8.6% to 7.2%. The International segment showed over 100% growth in EBITDA and revenues, buoyed by a full quarter of KBC's inclusion. Operating cash flow greatly improved to approximately EUR 70 million in Q3, with expectations for year-end cash flow between EUR 70 million to over EUR 100 million. Capital expenditures (CapEx) were around 1.7% of sales with projected Q4 CapEx between EUR 6 million and EUR 7 million. CANCOM's share buyback utilized EUR 44.5 million, about 4.56% of their capital.

Show Full Analysis

Management

Mr. Kevin G. Guest
Executive Chairman
No Bio Available
Mr. Jim Brown
CEO & President
No Bio Available
Mr. G. Douglas Hekking
Chief Financial Officer
No Bio Available
Mr. Walter Noot
Chief Operating Officer
No Bio Available
Mr. P. Joshua Foukas J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
No Bio Available
Mr. Daniel A. Macuga Jr.
Chief Communications & Marketing Officer
No Bio Available
Dr. Myron W. Wentz Ph.D.
Founder & Chairman Emeritus
No Bio Available
Dr. John Cuomo
Executive Director of Product Development & Technology
No Bio Available
Dr. Robert A. Sinnott M.N.S., Ph.D.
Chief Scientific Officer
No Bio Available
Peter Benedict
Chief Information Officer
No Bio Available

Contacts

Address
UTAH
Salt Lake City
3838 W Parkway Blvd
Contacts
+18019547100.0
www.usana.com